Sanara MedTech (SMTI) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Utah Medical Products (UTMD) has outperformed Sanara MedTech (SMTI) over the past year, gaining 16.5% versus a gain of 8.4%. Over five years, SMTI leads with a +6.3% price change compared with -17.9% for UTMD. Sanara MedTech is the larger company by market cap ($322.2 million vs $236.6 million), about 1.4 times the size.
Utah Medical Products pays a dividend yielding 1.66%, while Sanara MedTech does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SMTI | UTMD |
|---|---|---|
| Share price | $35.07 | $74.54 |
| Market cap | $322.22M | $236.58M |
| 1-day change | +0.06% | +0.90% |
| YTD return | +50.11% | +32.01% |
| 1-year return | +8.41% | +16.47% |
| 5-year return | +6.28% | -17.93% |
| P/E ratio (TTM) | — | 22.73 |
| Forward P/E | 64.94 | — |
| EPS (TTM) | $-0.04 | $3.28 |
| Dividend yield | 0.00% | 1.66% |
| Annual dividend | $0.00 | $1.24 |
| 52-week high | $35.34 | $76.89 |
| 52-week low | $16.05 | $53.66 |
| Distance from 52-week high | -0.76% | -3.06% |
| Analyst consensus | none | — |
| Avg. price target upside | -0.20% | — |
| Average volume | 280.40K | 34.56K |
| Shares outstanding | 9.19M | 3.17M |
| Employees | 108 | 140 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Utah Medical Products offers a meaningfully higher dividend yield (1.66% vs 0.00%).
About Sanara MedTech
SMTI stock →Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns.
Health Care · Industrial Specialties · 108 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
SMTI vs UTMD FAQ
Which is bigger, Sanara MedTech or Utah Medical Products?
Sanara MedTech (SMTI) is larger, with a market capitalization of $322.22M compared with $236.58M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, SMTI or UTMD?
UTMD returned +16.47% over the past 12 months, compared with +8.41% for SMTI (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Sanara MedTech or Utah Medical Products?
Utah Medical Products pays a dividend yielding 1.66%, while Sanara MedTech does not currently pay a regular dividend.
Are Sanara MedTech and Utah Medical Products in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Sanara MedTech and Medical/Dental Instruments for Utah Medical Products.